Baird analyst Jack Allen maintains Frequency Therapeutics (NASDAQ:FREQ) with a Outperform and lowers the price target from $10 to $4.
Baird Maintains Outperform on Frequency Therapeutics, Lowers Price Target to $4
Baird analyst Jack Allen maintains Frequency Therapeutics (NASDAQ:FREQ) with a Outperform and lowers the price target from $10 to $4.
Related Posts
Trump Lawyers To Get Revised Inventory Of Items Seized From Mar-A-Lago: What You Should Know
The U.S. Department of Justice has filed a revised inventory of items seized from Mar-a-Lago, the Florida estate of former President Donald Trump.
Apple Introduces ‘Groundbreaking Security Capability’ For Some Users: Here’s What It’s All About
Apple Inc (NASDAQ: AAPL) is previewing a measure to protect people who face sophisticated cyberattacks.
Benchmark Maintains Buy on The Middleby, Raises Price Target to $175
Benchmark analyst Todd Brooks maintains The Middleby (NASDAQ:MIDD) with a Buy and raises the price target from $170 to $175.